A review of psychedelics trials completed in depression, informed by European regulatory perspectives.
Neuroscience applied.. 2025 Francisca Silva, Florence Butlen-Ducuing, Lorenzo Guizzaro et al. 4 citations
There is a growing body of clinical research on the therapeutic potential of psychedelics for the treatment of mental health disorders, notably depression. Accordingly, the new revision of the European Medicines Agency guideline on the clinical investigation of products for depression will incorporate a section covering specific regulatory recommendations for the design of studies with...